Suchbegriffe: SPIRONOLACTONE - PHARMACOLOGY , . Treffer: 4
Alesutan, I; Voelkl, J; Feger, M; Kratschmar, DV; Castor, T; Mia, S; Sacherer, M; Viereck, R; Borst, O; Leibrock, C; Gawaz, M; Kuro-O, M; Pilz, S; Tomaschitz, A; Odermatt, A; Pieske, B; Wagner, CA; Lang, F
Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells.
Sci Rep. 2017; 7(1):2059-2059
Doi: 10.1038/s41598-017-01882-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Verheyen, N; Grübler, MR; Meinitzer, A; Trummer, C; Schwetz, V; Amrein, K; Dimai, HP; März, W; Catena, C; von Lewinski, D; Voelkl, J; Alesutan, I; Fahrleitner-Pammer, A; Brussee, H; Pilz, S; Tomaschitz, A
Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism - The randomized, placebo-controlled EPATH trial.
Bone. 2017; 105(5):212-217
Doi: 10.1016/j.bone.2017.08.030
Web of Science
PubMed
FullText
FullText_MUG
Edelmann, F; Gelbrich, G; Duvinage, A; Stahrenberg, R; Behrens, A; Prettin, C; Kraigher-Krainer, E; Schmidt, AG; Düngen, HD; Kamke, W; Tschöpe, C; Herrmann-Lingen, C; Halle, M; Hasenfuss, G; Wachter, R; Pieske, B
Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction--results of the Aldo-DHF trial.
Int J Cardiol. 2013; 169(6):408-417
Doi: 10.1016/j.ijcard.2013.10.018
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pippal, JB; Cheung, CM; Yao, YZ; Brennan, FE; Fuller, PJ
Characterization of the zebrafish (Danio rerio) mineralocorticoid receptor.
Mol Cell Endocrinol. 2011; 332(1-2):58-66
Doi: 10.1016/j.mce.2010.09.014
Web of Science
PubMed
FullText
FullText_MUG